Mark Schuppert1, Kai Herz1, Anagha Deshmane1, and Moritz Zaiss1
1High-field Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tuebingen, Germany
Synopsis
Using volumetric snapshot-GRE CEST MRI at 9.4T with high
frequency sampling, we were able to separate novel CEST peaks at +2.7 ppm, +1.2
ppm and -1.7 ppm reliably in the CEST-spectrum and showed creation of maps of these
CEST MRI contrasts in the healthy human brain to be feasible in vivo.
INTRODUCTION
Chemical
exchange saturation transfer (CEST) enables an intrinsic MRI contrast of
solutes (i.e. metabolites) by proton exchange with the abundant water pool. Due
to the improved spectral resolution, as well as the higher SNR, and generally
longer T1 at higher B0 field strengths, CEST effects in tissue are
easier to detect, separate and associate with certain chemical shifts [1]. Application
of a volumetric snapshot-GRE CEST MRI optimized for 9.4T [3] showed the known
effects at +3.5 ppm, +2 ppm and -3.5 ppm, but also showed peaks at +2.7 ppm,
+1.2 ppm and -1.7 ppm well-separated for the first time in the human brain in
vivo.METHODS
CEST
MRI measurements were performed on a 9.4T whole-body MRI scanner (MAGNETOM,
Siemens, Erlangen, Germany) using an in-house build 16Tx/31Rx-coil [2] and a 3D
GRE [3] sequence in three healthy volunteers at nominal B1 = 1.2
µT, 0.9 µT, and 0.6 µT. Simultaneous B0 and B1 mapping
was performed using the WASABI method [4]. B0 correction was
performed pixel-wise using the WASABI B0 map. The 3-point-Z-correction as
described by Windschuh et al. [5] was used for B1-inhomogeneity
correction. CEST contrast images were calculated from B0- and B1-corrected
Z-spectra using Lorentzian difference (LD) MTR_LD as proposed by Jones et al.
[6]. MTR_LD was subsequently fitted by a 5-pool Multi-Lorentzian model [5].RESULTS & DISCUSSION
Figure 1 a) and c) show the acquired highly-resolved
Z-spectra at 9.4T for regions in gray and white matter at different effective B1
values. Scans of three different nominal B1 power levels and a B1
map (Figure 4) were used to create the B1-corrected Z-spectrum stack in the
whole brain. Figure 1 b) and d) reveal that this correction leads to
reproducible gray and white matter Z-spectra in three different volunteers. With
validated feasibility and reproducibility more detailed analysis can be
performed.
By removal of the water and MT background by Lorentzian
difference (LD) calculation, the individual CEST peaks can be investigated in
the MTR_LD-spectrum in gray and white matter (Figure 2a and b). The +2.7 ppm
and -1.7 ppm resonance could be detected reliably in 3 healthy volunteers. Figure
2c shows the averaged spectrum of the three volunteers, presented as mean ± standard
deviation. Investigation of the according CEST contrast images (Figure 2d)
consistently showed stronger gray matter contrast at positive irradiation
frequency offsets and stronger white matter contrast at negative irradiation
frequency offsets.
To further separate the different resonances a 5 pool
Multi-Lorentzian fit model was fitted to the MTR_LD stack. Figure 3 a) and b)
shows the fit results in a typical gray and white matter voxel, figure c-e show
the isolated resonances at 3.5 ppm, 2 ppm and -3.5 ppm as already detected at
7T [7], while f,g, and h show CEST contrast that were until now not yet reported
in vivo. While the 2.7 ppm resonance shows higher signals in grey matter, the
1.2 ppm resonance is especially elevated in the frontal WM regions. The -1.7
ppm peak showed surprisingly strong signals in vessels which might be attribute
to red-blood-cell CEST effects [8] and were investigated in detail in a
separate abstract.
In all contrasts (Figures
2,3), strong noise artifacts still appear in the region of lowest B1 as seen in
Figure 4. This large variability in the B1 distribution across the
field of view is a major challenge at ultra-high field, however current
developments in parallel transmission techniques may allow mitigation of B1
inhomogeneities in the near future and make the presented approach more
reliable and faster.
CONCLUSION
To
our knowledge, the present study reports the most precise CEST measurement of
the human brain in vivo. The high spectral resolution at 9.4T combined with a
spectral sampling with 95 offsets revealed as yet unidentified CEST peaks
robustly. In addition, maps of the individual peaks could be generated and
showed different contrast in the brain, generating possibilities for future use
as biomarker.Acknowledgements
The financial support of the Max Planck and Society, German
Research Foundation (DFG, grant ZA 814/2-1, support to M.Z., M.S., and K.H.), and European
Union’s Horizon 2020 research and innovation programme (Grant Agreement No.
667510, support to M.Z., A.D.) is gratefully acknowledged.References
[1]
Zaiss et al. PMB (2013), 58(22):R221-69
[2]
G. Shajan et al., MRM (2014)
71(2):870-79
[3] Zaiss et al., ISMRM (2017) #3768
[4] Schuenke et al., MRM (2017)
77(2):571-580
[5] Windschuh et al., NBM (2015)
28(5):529-37
[6] Jones et al., Neuroimage (2013)
77:114-124
[7] Zaiss et al. Neuroimage.(2015)
112:180-188
[8] Shah et al. NeuroImage (2017) 2017.10.053